Literature DB >> 12398232

Adrenocortical function and chronic lung disease of pre-maturity: an unresolved problem?

C Romagnoli1, C Latella, E Zecca, P Papacci, G Tortorolo.   

Abstract

The aim of this study was to investigate the relationship between adrenocortical function and chronic lung disease (CLD) of pre-term infants. Plasma F and ACTH were measured at 7, 14, 21 and 28 days of life in 25 pre-term infants with gestational age < or = 32 weeks and birth weight < or = 1,250 g. Fourteen infants developed CLD (CLD group) and 11 recovered without CLD (NOCLD group). Response to ACTH stimulation was tested on days 7 and 28. The results show that at the 7th day of life plasma F and ACTH levels were similar in the NOCLD and CLD group. CLD group had significantly higher plasma F and ACTH concentrations at the 14th (p=0.006 for F and p=0.020 for ACTH) and at the 21st (p=0.008 for F and p=0.024 for ACTH) day of life, while no significant differences were detected at the 28th day of life. The response to ACTH stimulation test was similar between the NOCLD and CLD group. These data demonstrate the lack of any significant association between adrenal insufficiency and CLD and discourage the use of baseline or stimulated plasma F levels to predict the development of CLD in pre-term infants.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12398232     DOI: 10.1007/BF03345508

Source DB:  PubMed          Journal:  J Endocrinol Invest        ISSN: 0391-4097            Impact factor:   4.256


  30 in total

1.  Adrenal suppression versus clinical glucocorticoid deficiency in the premature infant: no simple answers.

Authors:  G P Chrousos
Journal:  J Clin Endocrinol Metab       Date:  2001-02       Impact factor: 5.958

2.  Multiple courses of antenatal corticosteroids and outcome of premature neonates. North American Thyrotropin-Releasing Hormone Study Group.

Authors:  B A Banks; A Cnaan; M A Morgan; J T Parer; J D Merrill; P L Ballard; R A Ballard
Journal:  Am J Obstet Gynecol       Date:  1999-09       Impact factor: 8.661

3.  Prophylactic ibuprofen therapy of patent ductus arteriosus in preterm infants.

Authors:  M P De Carolis; C Romagnoli; V Polimeni; F Piersigilli; E Zecca; P Papacci; A B Delogu; G Tortorolo
Journal:  Eur J Pediatr       Date:  2000-05       Impact factor: 3.183

Review 4.  Bronchopulmonary dysplasia: early diagnosis, prophylaxis, and treatment.

Authors:  A Greenough
Journal:  Arch Dis Child       Date:  1990-10       Impact factor: 3.791

5.  Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease.

Authors:  J Mayenknecht; S Diederich; V Bähr; U Plöckinger; W Oelkers
Journal:  J Clin Endocrinol Metab       Date:  1998-05       Impact factor: 5.958

6.  Cortisol and cortisone levels in the cord blood at delivery of infants with and without the respiratory distress syndrome.

Authors:  B E Murphy
Journal:  Am J Obstet Gynecol       Date:  1974-08-15       Impact factor: 8.661

7.  Reproducibility of the cortisol response to stimulation with a low dose of ACTH(1-24): the effect of basal cortisol levels and comparison of low-dose with high-dose secretory dynamics.

Authors:  S Crowley; P C Hindmarsh; J W Honour; C G Brook
Journal:  J Endocrinol       Date:  1993-01       Impact factor: 4.286

Review 8.  Clinical review 62: Laboratory assessment of adrenal insufficiency.

Authors:  S K Grinspoon; B M Biller
Journal:  J Clin Endocrinol Metab       Date:  1994-10       Impact factor: 5.958

9.  Response to ACTH in the newborn.

Authors:  S Thomas; J F Murphy; J Dyas; M Ryalls; I A Hughes
Journal:  Arch Dis Child       Date:  1986-01       Impact factor: 3.791

10.  Evidence of early adrenal insufficiency in babies who develop bronchopulmonary dysplasia.

Authors:  K L Watterberg; S M Scott
Journal:  Pediatrics       Date:  1995-01       Impact factor: 7.124

View more
  1 in total

1.  Early pituitary-adrenal response and respiratory outcomes in preterm infants.

Authors:  P C Ng; C H Lee; C W K Lam; K C Ma; I H S Chan; E Wong; T F Fok
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-03       Impact factor: 5.747

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.